The jumps will be held as part of the 2
nd Annual 22Jumps event at Camelback Mountain in Phoenix, AZ, beginning 6 am (MST) and continuing throughout the day.
Wimmer s brother took his own life in 2015 after sustaining a traumatic brain injury (TBI) in Iraq while serving in the United States Marine Corps. The event, 22Jumps, started last year as a tribute to his brother, but quickly drew local and national media attention, as well as support from the brain injury, mental health, and Veterans communities, and countless families affected by Veteran suicide. In the past year, Wimmer s effort, 22Jumps.org, has grown into a nationwide initiative, with Veterans pledging to plan and participate in future events throughout the U.S. and all funds raised supporting Cohen Veteran Bioscience (CVB), a nonprofit biomedical research organization that is dedicated to fast-tracking precision diagnostics and tailored therapeutics for brain trauma, a major risk factor for suicide.
Seelos Therapeutics Announces Year End 2020 Business Update
-Highlights of Continued Execution of Plans for Multiple Clinical Programs and Upcoming Catalysts
-Additions to the Clinical, Operational and Regulatory Teams
News provided by
Share this article
Share this article
NEW YORK, Jan. 6, 2021 /PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced its year end 2020 business update. This past year marked the most significant 12 months in Seelos Therapeutics history despite being an otherwise challenging year due to the COVID-19 pandemic. We completed our safety trial for the intranasal ketamine program and began opening centers for our pivotal trial for Acute Suicidal Ideation and Behavior in patients with major depressive disorder. The trehalose program s pivotal study in ALS was accepted into the HEALEY ALS Platform